Literature DB >> 17316355

Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition.

J Yao1, L Duan, M Fan, J Yuan, X Wu.   

Abstract

Notch signaling can serve as a tumor suppressor or tumor promoter in the same kind of cancer, such as human papillomavirus-positive cervical cancer cells. However, the exact mechanisms remain poorly characterized. Our studies demonstrated that constitutively overexpressed active Notch1 via stable transfection with exogenous intracellular domain of Notch1 (ICN) resulted in growth inhibition of the human cervical cancer cell line HeLa by inducing G(2)-M arrest and apoptosis. Moreover, the growth inhibition was correlated with inhibition of nuclear factor kappa B (NF-kappaB) p50 activation, accompanied by a decrease in the nuclear expression of NF-kappaB p50 and an increase in the cytosolic expression of IkappaBalpha. Consistent with these results, downregulation of cyclin D1 and Bcl-2, which are both the downstream genes of NF-kappaB, were observed in ICN-overexpressed cells. Overall, our results suggest that NF-kappaB inhibition may contribute partially to cell cycle arrest and apoptosis induced by Notch1 activation in human cervical cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316355     DOI: 10.1111/j.1525-1438.2007.00872.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  13 in total

1.  Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.

Authors:  Laura G Franko-Tobin; L Vienna Mackey; Wei Huang; Xiangwei Song; Baofeng Jin; Jing Luo; Lynsie M Morris; Minqiu Liu; Joseph A Fuselier; David H Coy; Lizi Wu; Lichun Sun
Journal:  Oncologist       Date:  2012-01-30

2.  Yes-associated protein 1 promotes the metastasis of U251 glioma cells by upregulating Jagged-1 expression and activating the Notch signal pathway.

Authors:  Bin Hao; Xin Chen; Yiqun Cao
Journal:  Exp Ther Med       Date:  2018-06-19       Impact factor: 2.447

Review 3.  Notch signaling proteins: legitimate targets for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

4.  p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1.

Authors:  Kyra Nicole Laubach; Wensheng Yan; Xiangmudong Kong; Wenqiang Sun; Mingyi Chen; Jin Zhang; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-26       Impact factor: 12.779

Review 5.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

Review 6.  Notch tumor suppressor function.

Authors:  G P Dotto
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

7.  Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling.

Authors:  N Brimer; C Lyons; A E Wallberg; S B Vande Pol
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

8.  Camel Urine Promotes Sensitization to Doxorubicin by Inhibiting Epithelial-Mesenchymal Transition and Modulating NF-κB-Snail Signaling Pathway in Breast Cancer Cells.

Authors:  Mashael Saqer Al-Mutairi; Ibtehal Kamal Matar; Suad Alfadli; Awated Al-Mutairi
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

9.  Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells.

Authors:  Wei Chen; Gang Cao; Xinran Yuan; Xiang Zhang; Qingqing Zhang; Yinglan Zhu; Zhen Dong; Senlin Zhang
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

10.  Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.

Authors:  Shan Shao; Xiaoai Zhao; Xiaojin Zhang; Minna Luo; Xiaoxiao Zuo; Shangke Huang; Ying Wang; Shanzhi Gu; Xinhan Zhao
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.